AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Celldex Therapeutics, Inc. Director's Dealing 2024

Nov 20, 2024

31801_dirs_2024-11-20_fe47e834-3eec-45dc-96e1-7c75fd2c9f2d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2024-11-18

Reporting Person: MARINO JAMES J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-18	Common Stock	G	10500	—	Disposed	2204	Direct

Footnotes

F1: This transaction represents a gift transfer to an immediate family member of the reporting person who does not share the same household as the reporting person.